Legislators: Bring all stakeholders to the table to lower drug costs Article Legislators: Bring all stakeholders to the table to lower drug costs BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…Certara2021年3月30日
Strategic Evidence & Value Communication Symposium On-Demand Webinar Strategic Evidence & Value Communication Symposium Join us on 2021年4月21日 (水曜日), from12:00 PM – 2:00 PM EDT for Certara’s…Certara2021年3月26日
Getting Gene Therapies to Patients Blog 遺伝子治療を患者へ届けるために This blog discusses the challenges that drug developers face in getting patients access to cell…Certara2021年2月16日
Early Value Assessment in Gene Therapy Clinical Trial Design Case Study 遺伝子治療臨床試験デザインにおける早期価値評価 A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…Jim Gallagher2021年2月12日
BaseCase Interactive for Medical Affairs Brochure BaseCase Interactive for Medical Affairs Jim Gallagher2021年1月28日
Getting Real with RWE Article Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020年11月20日
The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal White Paper The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal Jim Gallagher2020年10月28日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU On-Demand Webinar SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU In this webinar, our experts provided an overview of the SNDS and the key working…Jim Gallagher2020年10月20日
Payment Pressures in U.S. Specialty: Status quo and outlook for future financing On-Demand Webinar Payment Pressures in U.S. Specialty: Status quo and outlook for future financing To allow for the optimal positioning of your product, portfolio, or company, it is critical…Certara2020年9月15日